ES2177593T3 - Formulaciones que contienen esculosido y uso de las mismas en los campos farmaceutico y cosmetico. - Google Patents

Formulaciones que contienen esculosido y uso de las mismas en los campos farmaceutico y cosmetico.

Info

Publication number
ES2177593T3
ES2177593T3 ES95110463T ES95110463T ES2177593T3 ES 2177593 T3 ES2177593 T3 ES 2177593T3 ES 95110463 T ES95110463 T ES 95110463T ES 95110463 T ES95110463 T ES 95110463T ES 2177593 T3 ES2177593 T3 ES 2177593T3
Authority
ES
Spain
Prior art keywords
sculoside
same
pharmaceutical
formulations containing
superflua
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95110463T
Other languages
English (en)
Inventor
Ezio Bombardelli
Aldo Cristoni
Paolo Morazzoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2177593T3 publication Critical patent/ES2177593T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE UN ESCULOSIDO POR SI SOLO O COMBINADO CON ESTIMULADORES DE LA CICLASA DEL ADENILATO, TAL COMO LA FORESCOLINA O DITERPENOS DE SALVIA MILTIORRHIZA Y/O CON INHIBIDORES DE LA FOSFODIESTERASA, TALES COMO FLAVONAS DIMERICAS CON UNA ESTRUCTURA DE APIGENINA, EN FORMULACIONES TOPICAS PARA EL TRATAMIENTO DE VASCULOPATIAS PERIFERICAS RELACIONADAS CON UNA MICROCIRCULACION PERIFERICA DETERIORADA, CELULITIS O ESTADOS POCO ETICOS RELACIONADOS CON UN DEPOSITO DE GRASA SUPERFLUA. PARA LA REDUCCION DEL DEPOSITO DE GRASA SUPERFLUA, CUALQUIERA QUE SEA LA CAUSA, LOS PRODUCTOS ARRIBA MENCIONADOS SE PUEDEN COMBINAR TAMBIEN CONVENIENTEMENTE CON CAFEINA, TEOFILINA O DERIVADOS DE LAS MISMAS.
ES95110463T 1994-07-12 1995-07-05 Formulaciones que contienen esculosido y uso de las mismas en los campos farmaceutico y cosmetico. Expired - Lifetime ES2177593T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941446A IT1270602B (it) 1994-07-12 1994-07-12 Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico

Publications (1)

Publication Number Publication Date
ES2177593T3 true ES2177593T3 (es) 2002-12-16

Family

ID=11369257

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95110463T Expired - Lifetime ES2177593T3 (es) 1994-07-12 1995-07-05 Formulaciones que contienen esculosido y uso de las mismas en los campos farmaceutico y cosmetico.

Country Status (14)

Country Link
US (1) US5679358A (es)
EP (1) EP0692250B1 (es)
JP (1) JP2991642B2 (es)
KR (1) KR100255527B1 (es)
AT (1) ATE218339T1 (es)
AU (1) AU686381B2 (es)
CA (1) CA2153604C (es)
DE (1) DE69526882T2 (es)
DK (1) DK0692250T3 (es)
ES (1) ES2177593T3 (es)
HK (1) HK1011617A1 (es)
IT (1) IT1270602B (es)
PT (1) PT692250E (es)
SG (1) SG44320A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1245230A3 (en) * 1995-06-23 2003-11-26 Advanced Life Sciences Inc. Amentoflavone as an antiviral agent
BR9602919A (pt) * 1996-06-27 1999-01-12 Cosmeticos Natural Ind Com Composições cosméticas para o cuidado da pele
JP3768626B2 (ja) * 1996-12-02 2006-04-19 株式会社カネボウ化粧品 脂肪分解促進剤および痩身用皮膚化粧料
FR2774905B1 (fr) * 1998-02-17 2000-06-09 Codif International Sa Utilisation d'une composition cosmetique comportant au moins une substance qui comprend un groupement pyrone
JP2002506806A (ja) * 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚の外観を調節する組成物
AU767582B2 (en) * 1998-11-26 2003-11-20 Andrew John Pollitt The use of a botanical substance given in high dilution to treat or prevent pathologic infiltration of the phospholipid cytoplasmic outer membrane of the human cell
DE10009423A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Kosmetische und pharmazeutische Zubereitungen
WO2001074327A1 (en) * 2000-04-04 2001-10-11 Color Access, Inc. Composition for improving skin lipid barrier function
KR20030005204A (ko) * 2000-12-25 2003-01-17 가부시키가이샤 시세이도 교감신경 활성화 향료 조성물
EP1234572B1 (de) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
FR2836630B1 (fr) * 2002-03-01 2004-07-09 Lvmh Rech Utilisation cosmetique de la phytosphingosine comme agent amincissant et compositions cosmetiques contenant de la phytosphingosine
AU2003288109A1 (en) * 2002-11-22 2004-06-18 L'oreal Cosmetic composition, containing coumarin derivatives and lipophilic amino acid derivatives
FR2847466B1 (fr) * 2002-11-22 2004-12-24 Oreal Composition notamment cosmetique contenant des derives de coumarines et des derives lipophiles d'acide amine
ITMI20031427A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
ITMI20031428A1 (it) 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
DE10352602A1 (de) * 2003-11-11 2005-06-02 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat
ITMI20040214A1 (it) * 2004-02-10 2004-05-10 Aboca S P A Composizioni cosmetiche contenenti associazioni estratti di bulpeurum species e salvia milthiorriza per la riduzione ed il contenimento degli inestetismi della cellulite
JP2008523127A (ja) 2004-12-14 2008-07-03 メナリーニ リチェルケ ソシエタ ペル アチオニ セルライトの治療のための医薬品組成物
WO2012087779A2 (en) * 2010-12-21 2012-06-28 The Procter & Gamble Company Hair care compositions and methods to improve hair appearance
ITMI20110373A1 (it) * 2011-03-10 2012-09-11 Erbolario S R L L "composizioni cosmetiche per il trattamento degli inestetismi cutanei della cellulite"
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN109620840A (zh) * 2018-12-27 2019-04-16 江苏隆力奇生物科技股份有限公司 一种抗皮肤光老化的药物组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1175430A (en) 1914-10-20 1916-03-14 Albert Fry Road-grader.
AT275028B (de) * 1968-05-31 1969-10-10 Nattermann & Cie Arzneimittel Verfahren zur Gewinnung eines aescinreichen Wirkstoffkonzentrates aus Roßkastaniensamen
DE1939008A1 (de) * 1969-07-31 1971-02-11 Zander Dr Helmut Arzneimittelkombination zur Behandlung von Mangeldurchblutungen des Gehirns
FR2499405A1 (fr) * 1981-02-10 1982-08-13 Biotherm Composition cosmetique amincissante et anti-cellulitique a base d'un extrait de plante contenant des saponines, un extrait d'arnica montana l. et d'un extrait de noix de cola et son procede d'application
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
HU202743B (en) * 1988-06-24 1991-04-29 Richter Gedeon Vegyeszet Active ingredient composition comprising medicinal herb extracts, cosmetics comprising such active ingredient and process for producing medicinal and veterinary compositions
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
IT1233753B (it) * 1989-09-21 1992-04-14 Indena Spa Composizioni farmaceutiche ad attivita' sulla microcircolazione cutanea.
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders

Also Published As

Publication number Publication date
HK1011617A1 (en) 1999-07-16
JPH08169896A (ja) 1996-07-02
DE69526882D1 (de) 2002-07-11
CA2153604C (en) 2008-12-02
EP0692250B1 (en) 2002-06-05
DE69526882T2 (de) 2003-01-02
CA2153604A1 (en) 1996-01-13
EP0692250A2 (en) 1996-01-17
ATE218339T1 (de) 2002-06-15
ITMI941446A1 (it) 1996-01-12
DK0692250T3 (da) 2002-09-30
AU686381B2 (en) 1998-02-05
IT1270602B (it) 1997-05-07
JP2991642B2 (ja) 1999-12-20
US5679358A (en) 1997-10-21
SG44320A1 (en) 1997-12-19
AU2491995A (en) 1996-01-25
PT692250E (pt) 2002-09-30
KR100255527B1 (ko) 2000-05-01
EP0692250A3 (en) 1996-10-23
ITMI941446A0 (it) 1994-07-12

Similar Documents

Publication Publication Date Title
ES2177593T3 (es) Formulaciones que contienen esculosido y uso de las mismas en los campos farmaceutico y cosmetico.
SV1995000002A (es) Uso y obtencion de derivados tetraciclicos ref. 1233cv/vs
ES2175404T3 (es) Derivados de carbolina.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
ES2107851T3 (es) Formulacion acabada, estable, polifasica, acuosa, para productos activos protectores de las plantas y procedimiento para su obtencion.
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
ATE330959T1 (de) Allosterische adenosin-rezeptor-modulatore
ES2147294T3 (es) Compuestos terapeuticos.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
GEP20053511B (en) ) β-Carboline Derivatives Useful as Inhibitors of Phosphodiesterase
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
ES2167516T3 (es) Composiciones para el cuidado de la piel que contienen dimetilimidazolidinona y retinol o ester de retinilo.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE77047T1 (de) Sebosuppressive topische zubereitungen.
ES2160680T3 (es) Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
FI883719A0 (fi) Kombination av pyrimidinderivat och retinoider som separata komponenter foer att inducera och stimulera haorvaext och reducera haorfall.
DK0705102T3 (da) Anvendelse af corrinoider til topisk anvendelse ved hudsygdomme
PE83798A1 (es) Composiciones cosmeticas para el cuidado de la piel
ES2045157T3 (es) Composiciones cosmeticas de aplicacion topica y su procedimiento de preparacion.
MX9303985A (es) Nucleosidos terapeuticos.
ECSP044969A (es) Sales de derivados del acido 1,2,3,4-tetrahidroquinolin-2-carboxilico
AR003663A1 (es) Producto cosmetico capilar para la limpieza del cabello y cuero cabelludo y la remocion de piojos y liendres
BR0006419A (pt) Fórmula para preparacação de loção hidratante corporal